Forskning og kvalitetsforbedring i NorKog

Den norske Downs syndrom- og demensstudien

Prosjektinformasjon

Ansvarlig. Ellen Melbye Langballe

Fall og fallskader hos personer som utredes for kognitiv dysfunksjon

Prosjektinformasjon

Ansvarlig. Per Grønaas Farup

Variasjon ved diagnostisering av Mild kognitiv svikt i norske hukommelsesklinikker

Prosjektinformasjon

Ansvarlig. Susanne Miriam Sørensen Hernes

Årsaker til kjønnsforskjeller i Alzheimerssykdom

Prosjektinformasjon

Ansvarlig. Mari Aksnes

Normering av Klokketest-NR

Prosjektinformasjon

Ansvarlig. Karin Persson

Betydning av blodtrykk, kroppsmasseindeks, inflammasjon og genetikk for kognisjon og demens.

Prosjektinformasjon

Ansvarlig. Knut Hestad

Å forutsi tidlig Alzheimers sykdom

Prosjektinformasjon

Ansvarlig. Anders Martin Fjell

Signaldeteksjon i registerdata for å finne legemidler som påvirker risiko for demens

Prosjektinformasjon

Ansvarlig. Christian Jonasson

Normalverdier for norsk revidert Mini mental status evaluering (MMSE-NR2)

Prosjektinformasjon

Ansvarlig. Knut Engedal

Risiko for sykdom og død etter vanlige gynekologiske operasjoner.

Prosjektinformasjon

Ansvarlig. Trond Melbye Michelsen

Epigenetiske profiler i blod hos pasienter med demens og nevropsykiatriske symptomer EPIGEN

Prosjektinformasjon

Ansvarlig. Sverre Bergh

Pårørende og overgrep og vold blant hjemmeboende personer med demens

Prosjektinformasjon

Ansvarlig: Wenche Karin Malmedal

Kvantitativ EEG for diagnostisering av lett kognitiv svikt. NorMCI.

Prosjektinformasjon

Ansvarlig: Maria Barca

Diagnostisering av demens i Trøndelag

Prosjektinformasjon

Ansvarlig: Linda Gjøra

Inflamasjon ved demens: InflaDem

Prosjektinformasjon

Ansvarlig: Anne Brita Knapskog

Normaltrykkshydrocefalus, kognitive og motoriske endringer.

Prosjektinformasjon

Ansvarlig: Magnhild Dejgaard

Ganghastighet og redusert kognitiv funksjon

Prosjektinformasjon

Ansvarlig: Rannveig Eidholm

Endringer i arvematerialet og utvikling av sykdom. Epigen

Prosjektinformasjon

Ansvarlig: Sverre Bergh

Analyser av aldring og funksjonsnivå over tid

Prosjektinformasjon

Ansvarlig: Henrik Schirmer

Ekstracellulære vesikler som kilde til biomarkører for Alzheimers sykdom

Prosjektinformasjon: Ekstracellulære vesikler som kilde til biomarkører for Alzheimers sykdom – en pilotundersøkelse

Ansvarlig: Geir Selbæk

MicroRNA for diagnose og prediksjon av forløpet av Alzheimers sykdom

Prosjektinformasjon: MicroRNA for diagnose og prediksjon av forløpet av Alzheimers sykdom

Ansvarlig: Yehani Wedatilake

Strukturert MR

Prosjektinformasjon: Strukturert MR. Subtyper av personer med kognitive symptomer og demens -MRI

Ansvarlig: Karin Persson

Samisk geriatri

Prosjektinformasjon: Studie under planlegging

Ansvarlig: Knut Johnsen / Elena Kamycheva

Blodtrykk og demens

Prosjektinformasjon: Blodtrykkets betydning for demens

Ansvarlig: Knut Hestad

Biomarkører i blod og cerebrospinalvæske ved Alzheimers Sykdom

Prosjektinformasjon: Biomarkører i blod og cerebrospinalvæske ved Alzheimers sykdom

Ansvarlig: Nenad Bogdanovic

Alkoholbruk hos eldre med kognitiv svikt og demens

Prosjektinformasjon: Alkoholbruk hos eldre med kognitiv svikt og demens

Ansvarlig: Sverre Bergh

MultiLing- flerspråklighet

Prosjektinformasjon: Språk og kommunikasjon hos flerspråklige personer med demens

Ansvarlig: Jan Svennevig

MR, depresjon og demens

Prosjektinformasjon: MR forandringer hos pasienter med mild kognitiv svikt eller demens og samtidig depresjon

Ansvarlig: Maria Lage Barca

Språk og kognisjon ved aldring og demens

Prosjektinformasjon: Språk og kognisjon ved aldring og demens

Ansvarlig: Ingeborg Sophie Ribu

Flutemetamol bedring av sensitivitet og spesifisitet på undersøkelser

Prosjektinformasjon: Flutemetamol bedring av sensitivitet og spesifisitet på undersøkelser (PDF)

Ansvarlig: Mona-Elisabeth Rootwelt-Revheim

Psykometriske egenskaper for Montreal Cognitive Assessment (MoCA)

Prosjektinformasjon: Psykometriske egenskaper for Montreal Cognitive Assessment (PDF)

Ansvarlig: Geir Selbæk, Thea Skarpengland

Kartlegging av daglig fysisk aktivitet hos hjemmeboende personer med demens

Prosjektinformasjon: Kartlegging av daglig fysisk aktivitet hos hjemmeboende personer med demens (PDF)

Ansvarlig: Kristin Taraldsen

Validitet av kognitiv funksjonsinstrument KFI

Prosjektinformasjon: Validitet av kognitiv funksjonsinstrument (PDF)

Ansvarlig: Knut Engedal, Geir Selbæk

Romlig orientering hos personer med kognitive vansker

Prosjektinformasjon: Romlig orientering hos personer med hukommelsesvansker (PDF)

Ansvarlig:  Gro Tangen

Personer som utredes for demens i kommunehelsetjenesten – en beskrivelse og sammenligning med personer som utredes i spesialisthelsetjenesten

Prosjektinformasjon: Personer som utredes for demens i kommunehelsetjenesten (PDF)

Ansvarlig: Sverre Bergh, Mona Michelet

Hjerneendringer ved demens 

Ansvarlig: Ole Andreassen

Depression and neuropsychiatric symptoms in elderly: mechanisms and association with neurodegeneration

Prosjektinformasjon: Depression and neuropsychiatric symptoms in elderly (PDF)

Ansvarlig: Eirik Auning

Prognose ved demens og validitet av demensdiagnosen på dødsattesten

Prosjektinformasjon: Prognose ved demens og validitet av demensdiagnosen på dødsattesten (PDF)

Ansvarlig: Geir Selbæk

Hvem ser meg

Prosjektinformasjon: Hvem ser meg? (PDF)

Ansvarlig: Trine Skjellstad

Effekter av Vitamin D på fysisk og kognitiv funksjon

Prosjektinformasjon: Effekter av Vitamin D på fysisk og kognitiv funksjon (PDF)

Ansvarlig: Renate Pettersen

Kartlegging av daglig fysisk aktivitet hos hjemmeboende personer med demens

Prosjektinformasjon: Fysisk aktivitet hos hjemmeboende personer med demens (PDF)

Ansvarlig: Kristin Taraldsen

Resource Use and Disease Course in Dementia – REDIC

Prosjektinformasjon: Ressursbruk og sykdomsforløp ved demens (PDF)

Ansvarlig: Sverre Bergh

Agreement between test performance and carers information of cognitive impairment and IADL in memory clinic patients

Prosjektinformasjon: Agreement- studien (PDF)

Ansvarlig: Karin Persson

Hjelp til å huske – Arbeidsminnetrening av eldre med mild kognitiv svikt 

Prosjektinformasjon: Hjelp til å huske – Arbeidsminnetrening av eldre med mild kognitiv svikt (PDF)

Ansvarlig: Susanne Hernes, Marianne M Falck

Cognition and Neuropsychiatric Symptoms in Memory Clinic Patients 

Prosjektinformasjon: Cognition and Neuropsychiatric Symptoms in Memory Clinic Patients (PDF)

Ansvarlig: Geir Selbæk, Anne Sofie Helvik

IPOD-studien – Legemidler og utvikling av demens

Prosjektinformasjon: IPoD-D -studien (PDF)

Ansvarlig: Hege Kersten

Pårørende til personer med demens

Prosjektinformasjon: Pårørende til personer med ulik type demens (PDF)

Ansvarlig: Arvid Rongve

YOD-prosjektet (young onset dementia) 

Prosjektinformasjon: YOD-studien (Young Onset Dementia) (PDF)

Ansvarlig: Lara Hvidsten, Aud Johannesen

Kretsløpsregulering ved Alzheimers sykdom

Prosjektinformasjon: Kretsløpregulering ved Alzheimers sykdom (PDF)

Ansvarlig: Marte Mellingsæter

Kognitiv adferdsterapi ved demens

Prosjektinformasjon: Et kognitivt treningsprogram for personer med demens i tidlig sykdomsfase (PDF)

Ansvarlig: Johanne Tonga

DemGen-Alzheimers sykdom genetikk

Prosjektinformasjon: Alzheimers sykdom genetikk prosjekt (PDF)

Ansvarlig: Ole Andreassen, Ingun Ulstein

PrELOaD

Prosjektinformasjon: PrELOAD (PDF)

Ansvarlig: Anne Brita Knapskog

Validitet av demensmarkører i spinalvæske for Alzheimers sykdom

Prosjektinformasjon: Validitet av demensmarkører i spinalvæske for Alzheimers sykdom (PDF)

Ansvarlig: Anne Brita Knapskog

Multiple nutritional deficiencies causing Dementia of the Alzheimer type

Ansvarlig: Thomas Bøhmer, Ingun Ulstein

Functioning in community dwelling older people with mild cognitive impairment and dementia with a focus on instrumental activities of daily living and physical fitness

Prosjektinformasjon: Fysisk funksjon hos hjemmeboende eldre med kognitiv svikt (PDF)

Ansvarlig: Karin Hesselberg

Physical function in patients with different degrees of Alzheimer’s disease

Prosjektinformasjon: Fysisk funksjon hos personer med hukommelsesvansker (PDF)

Ansvarlig:  Gro Tangen

Depresjon blant pasienter med mild kognitiv svikt og mild demens av Alzheimers type

Prosjektinformasjon: Depresjon blant pasienter med MCI og mild demens av Alzheimers type (PDF)

Ansvarlig: Anne Brita Knapskog, Maria Lage Barca

Prognosis in Alzheimer’s disease and MCI with co-morbid depression (The PAD study)

Prosjektinformasjon: Progresjon ved Alzheimers sykdom med samtidig depresjon (PDF)

Ansvarlig:  Maria Barca, Karin Persson

Longitudinelle analyser av aldring og funksjonsnivå

Prosjektinformasjon: Longitudinelle analyser av aldring og funksjonsnivå

Ansvarlig: Henrik Schirmer

Hestad KA, Engedal K, Strand BH, Farup PG. 2 Predictors of Memory Deficits in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease – Do Disease Severity Moderate the Association? Journal of the International Neuropsychological Society. 2023; 29(s1):406-407. doi:10.1017/S1355617723005404

Engedal, Knut et al. ‘Normative Scores on the Norwegian Version of the Mini-Mental State Examination’. 1 Jan. 2023: 831 – 842.

Persson, K., Leonardsen, E.H., Edwin, T.H. et al. Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures. Sci Rep 13, 14957 (2023). https://doi.org/10.1038/s41598-023-42354-0

Knapskog A-B, Aksnes M, Edwin TH, et al. Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer’s disease. Alzheimer’s Dement. 2023;1-10. https://doi.org/10.1002/alz.13162, PubMed 37264981

Aksnes M, Edwin TH, Saltvedt I, Eldholm RS, Chaudhry FA, Halaas NB, Myrstad M, Watne LO, Knapskog AB. Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease. Biol Sex Differ. 2023 May 23;14(1):35. doi: 10.1186/s13293-023-00514-x. PUBMED 37221606

Tangen GG, Sverdrup K, Taraldsen K, Persson K, Engedal K, Bekkhus-Wetterberg P and Knapskog A-B (2023) Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort. Front. Aging Neurosci. 15:1101306. doi: 10.3389/fnagi.2023.1101306

Engedal K, Wagle J, Benth JŠ, Gjøra L, Skjellegrind HK, Selbæk G. Normverdier for kognitive tester i demensutredningen [Normative values for cognitive tests in dementia assessment]. Tidsskr Nor Laegeforen. 2023 May 2;143(7). Norwegian. doi: 10.4045/tidsskr.23.0180. PMID: 37158523.

Jansen IE, et al: 2022) Genome wide meta analysis for Alzheimer’s disease cerebrospinal fluid biomarkers. Acta Neuropathologica https://doi.org/10.1007/s00401-022-02454-z

Medbøen, Ingrid Tøndel; Persson, Karin Ester Torun; Nåvik, Marit; Totland, Torunn Holm; Bergh, Sverre; Treviño, Cathrine Selnes; Ulstein, Ingun; Engedal, Knut; Knapskog, Anne Brita; Brækhus, Anne; Øksengård, Anne Rita; Horndalsveen, Peter Otto; Saltvedt, Ingvild; Lyngroth, Anne Liv; Ranhoff, Anette Hylen; Skrettingland, Dagny B; Naik, Mala; Soares, Jelena Zugic; Johnsen, Bente; Selbæk, Geir Cohort profile: the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) – a national research and quality registry with a biomaterial collection BMJ Open 2022; 12: e058810. . doi: 10.1136/bmjopen-2021-058810

Kamsvaag B, Tevik K, Šaltytė Benth J, Wu B, Bergh S, Selbaek G, Helvik AS: Does Elevated Alcohol Consumption Delay the Diagnostic Assessment of Cognitive Impairment among Older Adults? Dementia and geriatric cognitive disorders extra 2022, 12(1):14-23.

Kamsvaag B, Bergh S, Šaltytė Benth J, Selbaek G, Tevik K, Helvik A-S: Alcohol consumption among older adults with symptoms of cognitive decline consulting specialist health care. Aging & Mental Health 2022, 26(9):1756-1764.

Barca ML, Alnæs D, Engedal K, Persson K, Eldholm RS, Siafarikas N, Selseth Almdahl I, Stylianou-Korsnes M, Saltvedt I, Selbæk G, Westlye LT. Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia. Dement Geriatr Cogn Dis Extra. 2022 Jun 23;12(2):107-114. doi: 10.1159/000521114. PMID: 35950148; PMCID: PMC9251457.

Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME.
Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer’s disease.Quant Imaging Med Surg. 2022 Jan;12(1):493-509.

Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB.
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease? J Alzheimers Dis. 2022;85(1):197-205

Persson K, Edwin TH, Knapskog AB, Tangen GG, Selbæk G, Engedal K. Hippocampal Atrophy Subtypes of Alzheimer’s Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications. Dement Geriatr Cogn Disord. 2022;51(1):80-89. doi: 10.1159/000522382. Epub 2022 Mar 28. PMID: 35344967.

Bellenguez C, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022 Apr;54(4):412-436. doi: 10.1038/s41588-022-01024-z. Epub 2022 Apr 4. PMID: 35379992; PMCID: PMC9005347.

Leonardsen EH, Peng H, Kaufmann T, Agartz I, Andreassen OA, Celius EG, Espeseth T, Harbo HF, Høgestøl EA, Lange AM, Marquand AF, Vidal-Piñeiro D, Roe JM, Selbæk G, Sørensen Ø, Smith SM, Westlye LT, Wolfers T, Wang Y. Deep neural networks learn general and clinically relevant representations of the ageing brain. Neuroimage. 2022 Aug 1;256:119210. doi: 10.1016/j.neuroimage.2022.119210. Epub 2022 Apr 21. PMID: 35462035.

Barca ML, Alnæsc D, Engedal K, Persson K, Eldholme RS, Siafarikas N, Almdahlg IS, Stylianou-Korsnes M, Saltvedt I, Selbæk G, Westly LT. 2022. Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia. Dementia and Geriatric Cognitive Disorders Extra, 12, 107-114.

Aksnes M, Aass HCD, Tiiman A, Terenius L, Bogdanović N, Vukojević V, Knapskog AB. Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort. J Alzheimers Dis. 2022;86(3):1459-1470. doi: 10.3233/JAD-215504.

Soares JZ, Valeur J, Šaltytė Benth J, Knapskog AB, Selbæk G, Bogdanovic N, Pettersen R. Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer’s Disease: A Cross-Sectional Study. J Alzheimers Dis. 2022 Aug 1. doi: 10.3233/JAD-220407. Online ahead of print. PMID: 35938253.

Henjum K, Watne LO, Godang K, Bodd-Halaas N, Eldholm RS, Blennow K, Zetterberg H, Saltvedt I, Bollerslev J, Knapskog AB. Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease. Transl Psychiatry. 2022 Apr 9;12(1):151. doi: 10.1038/s41398-022-01901-5. PMID: 35397615

Soares JZ, Valeur J, Šaltytė Benth J, Knapskog AB, Selbæk G, Arefi G, Gilfillan GD, Tollisen A, Bogdanovic N, Pettersen R. Vitamin D in Alzheimer’s Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum. J Alzheimers Dis. 2022;86(3):1301-1314. doi: 10.3233/JAD-215536. PMID: 35180126.

Soares, Jelena Zugic et al. ‘Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer’s Disease: A Cross-Sectional Study’. 1 Jan. 2022 : 825 – 834.

Soares JZ,  Pettersen R, Šaltytė, Persson K, Strobel C, Selbæk  G , Bogdanovic N. Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms. J Alzheimers Dis. 2021;79(1):311-321. doi: 10.3233/JAD-201018

B. Kamsvaag, S. Bergh, J. Saltyte Benth, G. Selbaek, K. Tevik and A. S. Helvik. Alcohol consumption among older adults with symptoms of cognitive decline consulting specialist health care. Aging Ment Health 2021 Pages 1-9. Accession Number: 34323134 DOI: 10.1080/13607863.2021.1950618

M. A. A. DeMichele-Sweet, L. Klei, B. Creese, J. C. Harwood, E. A. Weamer, L. McClain, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry 2021. Accession Number: 34112972 DOI: 10.1038/s41380-021-01152-8

Flugon SJ, Jøranson N, Tangen GG. Mobility and depressive symptoms in persons with mild cognitive impairment and Alzheimer dementia. J Neurol Phys Ther 2021 2021/09/11. DOI: 10.1097/NPT.0000000000000378

Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB. Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease? J Alzheimers Dis. 2022;85(1):197-205. doi: 10.3233/JAD-215046.

Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME. Evaluation of semi-quantitative measures of ¹⁸F-Flutemetamol PET for the clinical diagnoses of Alzheimer’s disease. Quant Imaging Med Surg. 2021 Jul 6. Doi:10.21037/qims-21-188.

Aksnes M, Aass HCD, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojević V, KnapskogAB. Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease. Transl Neurodegener. 2021 Jun 8;10(1):18. doi: 10.1186/s40035-021-00244-3. PMID: 34099032

Halaas NB, Zetterberg H, Idland AV, Knapskog AB, Watne LO, Blennow K. Cerebrospinal fluid concentration of Neurogranin in Hip Fracture patients with delirium. J Alzheimers Dis. 2021;81(2):667-677. doi: 10.3233/JAD-201341.PMID: 33814433.

Hernes SS, Flak MM, Løhaugen GCC, Skranes J, Hol HR, Madsen BO, Knapskog AB, Engvig A, Pripp A, Ulstein I, Lona T, Zhang X, Chang L. Working Memory Training in Amnestic and Non-amnestic Patients With Mild Cognitive Impairment: Preliminary Findings From Genotype Variants on Training Effects. Front Aging Neurosci. 2021 Feb 15;13:624253. doi: 10.3389/fnagi.2021.624253. eCollection 2021. PMID: 33658917

Edwin TH, Strand BH, Persson K, Engedal K, Selbæk G, Knapskog AB. Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort. Int J Geriatr Psychiatry. 2021 Jan 18. doi: 10.1002/gps.5500. Online ahead of print. PMID: 33462872

Aksnes A, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojevic V, Knapskog AB. Comparison of cerebrospinal fluid amyloidogenic nanoplaques with core biomarkers of Alzheimer’s disease. Front Aging Neurosci. 2021 Jan 8;12:608628. doi: 10.3389/fnagi.2020.608628. eCollection 2020. PMID: 33488383.

Hestad KA, Engedal K, Selbaek G, Strand BH. Blood pressure in dementia, mild cognitive impairment, and subjective cognitive decline related to time  of death. Brain Behav . 2021 May 9;e02166. doi: 10.1002/brb3.2166  

Hestad K, Engedal K, Horndalsveen P, Strand BH. Cognition in patients with memory difficulties and dementia relative to APOE e4 status. Frontiers in Psychology, 14 June 2021 | https://doi.org/10.3389/fpsyg. 2021.686036

Hestad KA, Horndalsveen PO and Engedal K (2021) Blood Pressure and T-Tau in Spinal Fluid Are Associated With Delayed Recall in Participants With Memory Complaints and Dementia of the Alzheimer’s Type. Front. Aging Neurosci. 13:652510. doi: 10.3389/fnagi.2021.652510

de Rojas, I., et al. (2021). “Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores.” Nature Communications 12(1): 3417.

Wightman, D. P., et al. (2021). “A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease.” Nat Genet 53(9): 1276-1282

Rokicki, J., et al. (2021). “Multimodal imaging improves brain age prediction and reveals distinct abnormalities in patients with psychiatric and neurological disorders.” Human Brain Mapping n/a(n/a).

Siafarikas, N., et al. (2021). “Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer’s disease with dementia.” Int Psychogeriatr 33(11): 1217-1228.

Tonga JB, Eilertsen DE, Solem IKL, Arnevik EA, Korsnes, Ulstein ID. Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety. American Journal of Alzheimer’s Disease & Other Dementias®, Volume 35, January-December 2020. https://journals.sagepub.com/doi/full/10.1177/1533317519885264

Tonga, J., Šaltytė Benth, J., Arnevik, E., Werheid, K., Korsnes, M., & Ulstein, I. (2021). Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: A randomized controlled trial. International Psychogeriatrics, 33(3), 217-231. doi:10.1017/S1041610220000216

Michelet M, Lund A, Strand BH, Engedal K, Selbaek G, Bergh S (2020): Characteristics of patients assessed for cognitive decline in primary healthcare, compared to patients assessed in specialist healthcare, Scandinavian Journal of Primary Health Care. https://doi.org/10.1080/02813432.2020.1753334

Bredholt TC, Psykometriske egenskaper for norsk oversettelse av Montreal Cognitive Assessment (MoCA) -en valideringsstudie; UIO

Hestad K, Engedal K, Horndalsveen P, Strand BH. Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline. Front Aging Neurosci. 2020 Aug 31;12:257. doi: 10.3389/fnagi. 2020.00257.

Edwin TH, Strand BH, Persson K, Engedal K, Selbæk G, Knapskog AB. Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort. Accepted for publication Int J of Ger Psychiatry Dec 2020

Edwin TH, Henjum K, Nilsson LNG, Watne LO, Persson K, Eldholm RS, Saltvedt I, Halaas NB, Selbæk G, Engedal K, Strand BH, Knapskog AB. A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer’s disease.  Alzheimers Dement (Amst). 2020 Dec 7;12(1):e12128. doi: 10.1002/dad2.12128. eCollection 2020. PMID: 33313376

Mjørud M, Selbæk G, Bjertness E, Edwin TH, Engedal K, Knapskog AB, Strand BH. Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis.  PLoS One. 2020 Dec 4;15(12):e0243513. doi: 10.1371/journal.pone.0243513. eCollection 2020. PMID: 33275638

Knapskog AB, Henjum K, Idland AV, Eldholm RS, Persson K, Saltvedt I, Watne LO, Engedal K, Nilsson LNG. Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification. Sci Rep. 2020 Sep 28;10(1):15886. doi: 10.1038/s41598-020-72878-8. PMID: 32985583

Edwin TH, Strand BH, Persson K, Engedal K, Selbæk G, Knapskog AB. Trajectories and risk factors of dementia progression: A memory clinic cohort followed up to three years from diagnosis. Int Psychogeriatr. 2020 Nov 20:1-11. doi: 10.1017/S1041610220003270. Online ahead of print. PMID: 33213607

Aksnes M, Müller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojević V, Bogdanović N, Knapskog AB. Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer’s Disease in a Memory Clinic Cohort. J Alzheimers Dis. 2020;77(2):831-842. doi: 10.3233/JAD-200237. PMID: 32741818 

Sajjad MU, Blennow K, Knapskog AB, Idland AV, Chaudhry FA, Wyller TB, Zetterberg H, Watne LO. Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients. J Alzheimers Dis. 2020 Jan 6. doi: 10.3233/JAD-190941.

Elvsåshagen T, Bahrami S et al.The genetic architecture of human brainstem structures and their involvement in common brain disorders. NATURE COMMUNICATIONS |  (2020) 11:4016 | https://doi.org/10.1038/s41467-020-17376 www.nature.com/naturecommunications

Ribu, I. S. B.: Language and cognition in healthy aging and dementia. PhD Dissertation, University of Oslo. http://urn.nb.no/URN:NBN:no-91493

Flak MM, Hol HR, Hernes SS, Chang L, Engvig A, Bjuland KJ, Pripp A, Madsen BO, Knapskog AB, Ulstein I, Lona T, Skranes J, Løhaugen GCC. Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Blind Active Controlled Trial. Front Psychol. 2019 Apr 12;10:807. doi: 10.3389/fpsyg.2019.00807 eCollection 2019.

Hvidsten, Lara H. Thomasgaard; Engedal, Knut; Selbæk, Geir; Wyller, Torgeir Bruun; Saltyte Benth, Jurate; Bruvik, Frøydis Kristine; Kersten, Hege. Quality of life of family carers of persons with young-onset compared to late-onset dementia. Aging & Mental Health 2019

Hvidsten, Lara H. Thomasgaard; Engedal, Knut; Selbæk, Geir; Wyller, Torgeir Bruun; Saltyte Benth, Jurate; Kersten, Hege. Quality of Life in People with Young-Onset Dementia: A Nordic Two-Year Observational Multicenter Study. Journal of Alzheimer’s Disease 2019 ;Volum 67.(1) s. 197-210

J. Zugic Soares, R. Pettersen, J. Saltyte Benth, A.B. Knapskog, G. Selbæk, N. Bogdanovic. Higher vitamin D levels are associated with better attentional functions: data from the NorCog register. Journal of nutrition, health and aging, 2019

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB. Oscillatory connectivity as a diagnostic marker of dementia due to Alzheimer’s disease. Clin Neurophysiol. 2019 Oct;130(10):1889-1899.

Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2019;51(3):404-13.

Creese B, Vassos E, Bergh S, Athanasiu L, Johar I, Rongve A, et al. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease. Translational psychiatry. 2019;9(1):273.

Leavey N, Hammond SP, Shepstone L, Cross J, Zetterberg H, Cunningham C, MacLullich A, Leiv Otto Watne, Minihane AM, Ballard C, Knapskog AB, Hall R, Howard G, Hammond M, Fox C. Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients. BMC Neurol. 2019 Sep 7;19(1):223. doi: 10.1186/s12883019-1447-7.

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME. Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic. PLoS One. 2019 Aug 20;14(8):e0221365. doi: 10.1371/journal.pone.0221365. eCollection 2019.

Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB. The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia. Alzheimer Dis Assoc Disord. 2019 Aug 13. doi: 10.1097/WAD.0000000000000342. [Epub ahead of print] PMID: 31414991

Strand BH, Knapskog AB, Persson K, Edwin TH, Bjertness E, Engedal K, Selbæk G. The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway. Dement Geriatr Cogn Disorders 2019.

Soares JZ,  Pettersen R, Šaltytė, Persson K, Strobel C, Selbæk  G , Bogdanovic N. Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms. J Alzheimers Dis. 2021;79(1):311-321. doi: 10.3233/JAD-201018.

Zugic Soares J, Pettersen R, Saltyte Benth J, Knapskog AB, Selbæk G, Bogdanovic N. Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register. J Nutr Health Aging. 2019;23(8):725-731. doi: 10.1007/s12603-019-1220-z. PMID: 31560030.

52. Helvik AS, Engedal K, Benth JS, Selbæk G, Time from Symptom Debut to Dementia Assessment by the Specialist Healthcare Service in Norway. Dement Geriatr Cogn Disord Extra 2018;8:117–127. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921216/pdf/dee-0008-0117.p

53. Flak MM, Hol HR, Hernes SS, Chang L, Ernst T, Engvig A, Bjuland KJ, Madsen B-O, Lindland EMS, Knapskog A-B, Ulstein ID, Lona TEE, Skranes J, Løhaugen GCC. Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients with Mild Cognitive Impairment. Front. Aging Neurosci. 2018;10:384. doi: 10.3389/fnagi.2018.00384

54. Barca ML, Eldholm RS, Persson K, Bjørkløf GH, Borza T, Telenius E,

Knapskog AB, Brækhus A, Saltvedt I, Selbæk G, Engedal K. Cortisol levels among older people with and without depression and dementia. Int Psychogeriatr. 2018 Dec 17:1-5. doi: 10.1017/S1041610218001199. [Epub ahead of print]. PMID: 30556798

55. Strand BH, Knapskog AB, Persson K, Edwin T H, Amland R, Mjorud M,

Bjertness E, Engedal K, Selbaek G. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway. PLoS One 2018 Sept 22. doi:10.1371/journal.pone.0204436.

56. Knapskog AB, Braekhus A, Engedal K. The effect of changing the amyloid β42 cut-off of cerebrospinal fluid biomarkers on Alzheimer’s disease diagnosis in a memory clinic population. Alzheimer Dis Assoc Disord 2018 Aug 13. doi:10.1097/wad.0000000000000268.

57. Eldholm RS, Persson K, Barca ML, Knapskog AB, Cavallin L, Engedal K,

Selbaek G, Skovlund E, Saltvedt I. Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics. BMC Geriatr May 22. doi: 10.1186/s12877-018-0813-4.

58. Eldholm RS, Barca ML, Persson K, Knapskog AB, Kersten H, Engedal K,

Selbæk G, Brækhus A, Skovlund E, Saltvedt I. Progression of Alzheimer’s

Disease: A Longitudinal Study in Norwegian Memory Clinics.J Alzheimers Dis. 2018;61(3):1221-1232. doi: 10.3233/JAD-170436.

59. Persson K, Barca ML, Cavallin L, Brækhus A, Knapskog AB, Selbæk G,

Engedal K. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer’s disease. Acta Radiol. 2017 Jan 1:284185117743778. doi: 10.1177/0284185117743778. [Epub ahead of print]

60. Persson K, Bohbot VD, Bogdanovic N, Selbaek G, Braekhus A, Engedal K. Finding of increased caudate nucleus in patients with Alzheimer’s disease.,. Acta Neurol Scand. 2018

61. Witoelar A, Rongve A, Almdahl IS, Ulstein ID, Engvig A, White LR, et al. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci. Sci Rep. 2018;8(1):18088.

62. Hvidsten L, Engedal K, Selbæk G, Wyller T.B, Bruvik F, Kersten H. Quality of Life in People with Young-Onset Alzheimer’s Dementia and Frontotemporal Dementia. Dementia and Geriatric Cognitive Disorders

63. Schjønning Nielsen M, Simonsen AH, Siersma V, Engedal K, Jelic V, Andersen BB, Naik M, Hasselbalch SG, Høgh P. Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study. Dement Geriatr Cogn Dis Extra. 2018 Nov 27;8(3):426-438.

64. Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB. EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer’s Disease. J Alzheimers Dis. 2018;64(4):1359-1371.

40. Doan NT, Engvig A, Zaske K, Persson K, Lund MJ, Kaufmann T, Cordova-Palomera A, Alnæs D, Moberget T, Brækhus A, Barca ML, Nordvik JE, Engedal K, Agartz I, Selbæk G, Andreassen OA, Westlye LT; Alzheimer’s Disease Neuroimaging Initiative. Distinguishing early and late brain aging from the Alzheimer’s disease spectrum: consistent morphological patterns across independent samples. Neuroimage. 2017 Sep;158:282-295. doi: 10.1016/j.neuroimage.2017.06.070. Epub 2017 Jun 27.

41. Doan NT, Engvig A, Persson K, Alnæs D, Kaufmann T, Rokicki J, Córdova-Palomera A, Moberget T, Brækhus A, Barca ML Engedal K, Andreassen OA, Selbæk G, Westlye LT. Dissociable diffusion MRI patterns of white matter microstructure and connectivity in Alzheimer’s disease spectrum. Sci Rep. 2017 Mar 24;7:45131. doi: 10.1038/srep45131.

42. Córdova-Palomera A, Kaufmann T, Persson K, Alnæs D, Doan NT, Moberget T, Lund MJ, Barca ML, Engvig A, Brækhus A, Engedal K, Andreassen OA, Selbæk G, Westlye LT1, Disrupted global metastability and static and dynamic brain connectivity across individuals in the Alzheimer’s disease continuum. Sci Rep. 2017 Jan 11;7:40268. doi: 10.1038/srep40268

43. Knapskog AB, Eldholm RS, Brækhus A, Engedal K, Saltvedt I,Factores that influence the level of cerebrospinal fluid biomarkers in memory clinic patients. BMC geriatrics(2017) 17:210, DOI 1q1 186/s 12877-01 061 1-4

44. Persson K, Eldholm RS, Barca ML,Cavallin L, Ferreira D, Knapskog AB, Selbæk G, Brækhus A, Saltvedt I, Westman E, Engedal K, MRI-assessed atrophy subtypes in Alzheimer’s disease and the cognitive reserve hypothesis. October 16, 2017 https://doi.org/10.1371/journal.pone.0186595

45. Persson K, Barca ML, Eldholm RS, Cavallin Le, Benth JS, Selbæk G, Brækhus A, Saltvedt I, Engedal K. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease. Dement Geriatr Cogn Disord 2017;44:12–24. 17. DOI: 10.1159/000477342

46. Barca ML, Persson K, Eldholm RS, Jūratė Šaltytė Benth JS, Kersten H, Knapskog AB, Saltvedt I, Selbaek G, Engedal K, Trajectories of depressive symptoms and their relationship to the progression of dementia. Journal of Affective Disorders 222 (2017) 146-152.

47. Tonga J. Ulstein ID,  Høye S, Kvaale K. The coping experiences of spouses of persons with dementia. Journal of Clinical Nursing, Volume 27, Issue 5-6

48. Córdova-Palomera A, Kaufmann T, Persson K, Alnæs D, Doan NT, Moberget T, Lund MJ, Barca ML, Engvig A, Brækhus A, Engedal K, Andreassen OA, Selbæk G, Westlye LT. Disrupted global metastability and static and dynamic brain connectivity across individuals in the Alzheimer’s disease continuum. Sci Rep. 2017 Jan 11;7:40268. doi: 10.1038/srep40268. PMID:28074926

49. Doan NT, Engvig A, Persson K, Alnæs D, Kaufmann T, Rokicki J, Córdova-Palomera A, Moberget T, Brækhus A, Barca ML, Engedal K, Andreassen OA, Selbæk G, Westlye LT. Dissociable diffusion MRI patterns of white matter microstructure and connectivity in Alzheimer’s disease spectrum. Sci Rep. 2017 Mar 24;7:45131. doi: 10.1038/srep45131.

50. Doan NT, Engvig A, Zaske K, Persson K, Lund MJ, Kaufmann T, Cordova-Palomera A, Alnæs D, Moberget T, Brækhus A, Barca ML, Nordvik JE, Engedal K, Agartz I, Selbæk G, Andreassen OA, Westlye LT; Distinguishing early and late brain aging from the Alzheimer’s disease spectrum: consistent morphological patterns across independent samples. Alzheimer’s Disease Neuroimaging Initiative. Neuroimage. 2017 Sep;158:282-295. doi: 10.1016/j.neuroimage.2017.06.070. Epub 2017 Jun 27.

51. Millenaar J, Hvidsten L, de Vugt M, Engedal K, SelbækG, Wyller TB, Johannessen A, Haugen PK, Bakker C,van Vliet D, Koopmans R, Verhey FRJ, Kersten H. Determinants of quality of life in young onset dementia – results from a European multicenter assessment. Aging & Mental Health 2017 ;Volum 21.(1) s. 24-30

29. Baptista MA, Santos RL, Kimura N, Lacerda IB, Johannenssen A, Barca ML, Engedal K, Dourado MC. Quality of life in young onset dementia: an updatedsystematic review. Trends Psychiatry Psychother. 2016 Mar;38(1):6-13.

30. Monteiro-Junior RS, da Silva Figueiredo LF, Maciel-Pinheiro PT, Abud EL, Braga AE, Barca ML, Engedal K, Nascimento OJ, Deslandes AC, Laks J. Acute effectsof exergames on cognitive function of institutionalized older persons: asingle-blinded, randomized and controlled pilot study. Aging Clin Exp Res. 2016 Jun 3. [Epub ahead of print] PubMed PMID: 27256080.

31. Persson K, Selbæk G, Brækhus A, Beyer M, Barca M, Engedal K. Fully automated structural MRI of the brain in clinical dementia workup. Acta Radiol. 2016 Sep 28. pii: 0284185116669874. [Epub ahead of print] PubMed PMID: 27687251.

32. Lyngroth A L, Hernes S M S ,Madsen B-O, Søderhamn U, Grov E K , Nutritional screening of patients at a memory clinic – association between patients’ and their relatives’ self-reports. © 2016 John Wiley & Sons Ltd 760 Journal of Clinical Nursing, 25, 760–768, doi: 10.1111/jocn.13093

33. Flak MM1, Hernes SS, Skranes J, Løhaugen GC. The Memory Aid study: protocol for a randomized controlled clinical trial evaluating the effect of computer-based working memory training in elderly patients with mild cognitive impairment (MCI). (http://www.ncbi.nlm.nih.gov/pubmed/24886034)

34. Svendsboe E, Terum T, Testad I, Aarsland D, Ulstein I, Corbett A, Rongve A. Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry. 2016 Jan 14. doi: 10.1002/gps.4433

35. Tonga JB, Arnevik EA, Werheid K , Ulstein ID (2016). Manual-based cognitive behavioral and cognitive rehabilitation therapy for young-onset dementia: a case report. International Psychogeriatrics, 28, pp 519-522. doi:10.1017/S1041610215001696.

36. Tangen GG, Bergland A, Engedal K, Mengshoel AM. The importance of parkinsonian signs for gait and balance in patients with Alzheimer’s disease of mild degree. Gait Posture. 2016;51:159-61.

37. Knapskog AB, Engedal K, Braekhus A. Performance of Cerebrospinal Fluid Biomarkers of Alzheimer Disease in a Memory Clinic in Norway. Alzheimer Dis Assoc Disord. 2016;30(1):8-14.

38. Durado M.C.N.,Laks J.,Kimura N.R., Baptista M.A.T., Barca M.L., Engedal K, Tveit, B& Johannesen A (2016). Youngonset Dementia: a comparison of Brazilian and Norwegian carers* eksperiences and needs for assistance. International Journal of geriatric Psychiatry.

39. Ferreira D, Jelic V, Cavallin L, Oeksengaard AR, Snaedal J, Høgh P, Andersen BB, Naik M, Engedal K, Westman E, Wahlund LO. Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers.Dement Geriatr Cogn Disord. 2016;42(1-2):80-92.

15. Tangen, G.G., Engedal, K., Bergland, A., Moger, T.A., Hansson O. & Mengshoel, A.M. Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer’s disease. Int Psychogeriatr. 2015 Aug;27(8):1401-9. (0) doi: 10.1017/S1041610215000022. Epub 2015 Feb 3.

16. Desikan, Rahul S.; Schork, Andrew J.; Wang, Yunpeng; Thompson, Wesley K.; Dehghan, Abbas; Ridker, Paul M.; Chasman, Daniel I.; McEvoy, Linda K.; Holland, Dominic; Chen, Chi-Hua; Karow, David S.; Brewer, James B.; Hess, Christopher P.; Williams, Julie; Sims, Rebecca; O’Donovan, Michael C.; Choi, Seung Hoan; Bis, Joshua C.; Ikram, M. Arfan; Gudnason, Vilmundur; DeStefano, Anita L.; Van Der Lee, Sven J.; Psaty, Bruce M.; Van Duijn, Cornelia M.; Launer, Lenore; Seshadri, Sudha; Pericak-Vance, Margaret A.; Mayeux, Richard; Haines, Jonathan L.; Farrer, Lindsay A.; Hardy, John; Ulstein, Ingun; Aarsland, Dag; Fladby, Tormod; White, Linda; Sando, Sigrid Botne; Rongve, Arvid; Witoelar, Aree; Djurovic, Srdjan; Hyman, Bradley T.; Snædal, Jon; Steinberg, Stacy; Stefansson, Hreinn; Stefánsson, Kári; Schellenberg, Gerard D.; Andreassen, Ole Andreas & Dale, Anders (2015). Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease. Circulation . ISSN 0009-7322. 131(23), s 2061- 2069 . doi: 10.1161/CIRCULATIONAHA.115.015489

17. Steinberg, Stacy; Stefansson, Hreinn; Jonsson, Thorlakur; Johannsdottir, Hrefna; Ingason, Andrés; Helgason, Hannes; Sulem, Patrick; Magnusson, Olafur Thor; Guðjónsson, Sigurjón Axel; Unnsteinsdottir, Unnur; Kong, Chung Tung Augustine; Helisalmi, Seppo; Soininen, Hilkka; Lah, James J.; Aarsland, Dag; Fladby, Tormod; Ulstein, Ingun; Djurovic, Srdjan; Sando, Sigrid Botne; White, Linda; Knudsen, Gun Peggy; Westlye, Lars Tjelta; Selbæk, Geir; Giegling, Ina; Hampel, Harald; Hiltunen, Mikko; Levey, AIlan I.; Andreassen, Ole Andreas; Rujescu, Dan; Jonsson, Palmi V.; Björnsson, Sigurbjörn; Snædal, Jon & Stefánsson, Kári (2015). Loss-of-function variants in ABCA7 confer risk of Alzheimer’s disease. Nature Genetics. ISSN 1061-4036. 47(5), s 455-447.doi: 10.1038/ng.3246

18. Hvidtsten L, Engedal K, Selbæk G, Wyller TB, Kersten H. Cognitive characteristics in persons with young onset Alzheimer’s disease and frontotemporal dementia in Norwegian memory clinics study population. European geriatric medicine 6:S186 · September 2015

19. Knapskog, A.B., K. Engedal, and A. Braekhus, Performance of Cerebrospinal Fluid Biomarkers of Alzheimer Disease in a Memory Clinic in Norway. Alzheimer Dis Assoc Disord, 2016. 30(1): p. 8-14.

20. Persson K, Anne Brækhus A, Selbæk G, Kirkevold Ø, Engedal K. Burden of Care and Patient’s Neuropsychiatric Symptoms Influence Carer’s Evaluation of Cognitive Impairment. Dement Geriatr Cogn Disord 2015;40:256–267

21. Tangen GG, Engedal K, Bergland A, Moger AT, Hansson O, Mengshoel AM. Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer’s disease. International Psychogeriatrics 2015

22. Mellingsæter M; Wyller TB; Ranhoff, A H; Bogdanovi N ,Wyller VB (2015). Reduced sympathetic response to head-up tilt in subjects with mild cognitive impairment or mild Alzheimer’s dementia. Dementia and geriatric cognitive disorders extra. ISSN 1664-5464. 5(1), s 107- 115 . doi:10.1159/000375297

23. Myhre J, Bjoernstad Tonga JB, Karlsoeen BK, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID. Challenges With Manual-Based Multimodal Psychotherapy for People With Alzheimer’s Disease: A Case Study. AM J ALZHEIMERS DIS OTHER DEMEN 1533317515603958, first published on September 17, 2015

24. Corinna Vossius, Geir Selbæk, Arnt Egil Ydstebø, Jurate Saltyte Benth, Geir Godager, Hilde Lurås, Sverre Bergh; Ressursbruk og sykdomsforløp ved demens (REDIC). Alderspsykiatrisk forskningssenter, Sykehuset Innlandet 2015

25. Barca ML, Engedal K, Selbaek G, Knapskog AB, Laks J, Coutinho E, Benth JŠ. Confirmatory factor analysis of the Cornell scale for depression in dementia among patient with dementia of various degrees. J Affect Disord. 2015 Dec1;188:173-8. doi: 10.1016/j.jad.2015.08.062. PubMed PMID: 26363614.

26. Vossius C., Selbæk G, Ydstebø A.E., | Benth J., S., Godager G, Hilde Lurås H, Bergh S.; Ressursbruk og sykdomsforløp ved demens (2015).

27. Hvidtsten L, Hisami T, Engedal K, Selbæk G, Wyller TB, Høgh P, Snaedal J, Johannessen A, Haugen PK, Kersten H. Young Onset Dementia study – A Prospective Cohort Study of Quality of Life and Specific Needs in Persons with Young Onset Dementia and their Families. Journal of Clinical Trials 2015 ;Volum 5.(1)

28. Engedal K, Snaedal J, Hoegh P, Jelic V, Bo Andersen B, Naik M, Wahlund LO, Oeksengaard AR. Quantitative EEG Applying the Statistical Recognition Pattern Method: A Useful Tool in Dementia Diagnostic Workup. Dement Geriatr Cogn Disord. 2015;40(1-2):1-12.

9. Hesseberg, K., Bentzen, H., & Bergland, A. (2014). Reliability of the Senior Fitness Test in Community Dwelling Older People with Cognitive Impairment. Physiotherapy Research International: The Journal For Researchers And Clinicians In Physical Therapy. DOI: 10.1002/pri.1594

10. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10.1056/NEJMoa1211103. Epub 2012 Nov 14.

11. Knapskog, A.B., M.L. Barca, and K. Engedal, Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia. Aging Ment Health, 2013.

12. Tangen, G.G., Engedal, K., Bergland, A., Moger, T.A., & Mengshoel, A.M. 2014. Relationships between Balance and Cognition in Patients with Subjective Cognitive Impairment, Mild Cognitive Impairment, and Alzheimer Disease. Phys Ther. 2014;94: 1123–1134. (5) doi: 10.2522/ptj.20130298. Epub 2014 Apr 24.

13. Barca, M.L., et al., Confirmatory factor analysis of the Cornell scale for depression in dementia among patient with dementia of various degrees. J Affect Disord, 2015. 188: p. 173-8. http://dx.doi.org/10.1016/j.jad.2015.08.062.

14. Flak MM, Hernes SS, Skranes J et al. The Memory Aid study: protocol for a randomized controlled clinical trial evaluating the effect of computer-based working memory training in elderly patients with mild cognitive impairment (MCI). Trials 2014;15:156 doi:10.1186/1745-6215-15-156 [PMC free article]

3. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K. Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10.1056/NEJMoa1211103. Epub 2012 Nov 14.

4. Hesseberg, K., Bentzen, H., Ranhoff, A. H., Engedal, K., & Bergland, A. (2013).Disability in instrumental activity of daily living in elderly patients with Mild Cognitive Impairment and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 36(3-4), 146-153. doi: 10.1159/000351010

5. Knapskog, A.B., M.L. Barca, and K. Engedal, A comparison of the cornell scale for depression in dementia and the Montgomery-Aasberg depression rating scale in a memory clinic population. Dement Geriatr Cogn Disord, 2013. 35(5-6): p. 256-65.

6. Knapskog, A.B., M.L. Barca, and K. Engedal, Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia. Aging Ment Health, 2013.

7. Knapskog, A.B., et al., A cross-cultural comparison of the phenotype of depression as measured by the Cornell Scale and the MADRS in two elderly outpatient populations. J Affect Disord, 2013. 144(1-2): p. 34-41.

8. Knapskog, A.B., M.L. Barca, and K. Engedal, A comparison of the cornell scale for depression in dementia and the Montgomery-Aasberg depression rating scale in a memory clinic population. Dement Geriatr Cogn Disord, 2013. 35(5-6): p. 256-65.

1. Knapskog, A.B., M.L. Barca, and K. Engedal, A comparison of the validity of the Cornell Scale and the MADRS in detecting depression among memory clinic patients. Dement.Geriatr.Cogn Disord., 2011. 32(4): p. 287-294

2. Ommundsen N, Engedal K, Øksengård AR Validity of the quantitative EEG statistical pattern recognition method in diagnosing Alzheimer’s disease. Dement Geriatr Cogn Disord. 2011;31(3):195-201